Duo Yun

Years Active: 2021-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Shuman Zhang, Duo Yun, Hao Yang, Markus Eckstein, Gihan Daw Elbait, Yaxing Zhou, Yanxi Lu, Hai Yang, Jinping Zhang, Isabella Dörflein, Nathalie Britzen-Laurent, Susanne Pfeffer, Marc P Stemmler, Andreas Dahl, Debabrata Mukhopadhyay, David Chang, Hang He, Siyuan Zeng, Bin Lan, Benjamin Frey, Chuanpit Hampel, Eva Lentsch, Paradesi Naidu Gollavilli, Christian Büttner, Arif Bülent Ekici, Andrew V Biankin, Regine Schneider-Stock, Paolo Ceppi, Robert Grützmann, Christian Pilarsky
Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer. Cell death discovery 10 (1) (2024)
Shuman Zhang, Duo Yun, Hao Yang, Markus Eckstein, Gihan Daw Elbait, Yaxing Zhou, Yanxi Lu, Hai Yang, Jinping Zhang, Isabella Dörflein, Nathalie Britzen-Laurent, Susanne Pfeffer, Marc P Stemmler, Andreas Dahl, Debabrata Mukhopadhyay, David Chang, Hang He, Siyuan Zeng, Bin Lan, Benjamin Frey, Chuanpit Hampel, Eva Lentsch, Paradesi Naidu Gollavilli, Christian Büttner, Arif Bülent Ekici, Andrew V Biankin, Regine Schneider-Stock, Paolo Ceppi, Robert Grützmann, Christian Pilarsky
Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer. Cell death discovery 10 (1) (2024)
Duo Yun, Zhirong Yang
Identification of a Four-lncRNA Prognostic Signature for Colon Cancer Based on Genome Instability. Journal of oncology 2021 (2021)

Duo Yun.css-eqlu8i{font-size:small;padding-left:4px;}